Related Experiment Videos
Atypical depression: current perspectives
Dorota Łojko1, Janusz K Rybakowski1,2
1Department of Adult Psychiatry.
Neuropsychiatric Disease and Treatment
|October 17, 2017
Summary
Atypical depression (AD) is defined by specific symptoms and affects a significant portion of depressed patients. Current research highlights its unique neurobiology and the need for updated diagnostic criteria and treatment guidelines.
Area of Science:
- Psychiatry
- Neuroscience
- Clinical Psychology
Background:
- Atypical depression (AD) is a subtype of depression with distinct clinical features.
- The diagnostic criteria for AD have evolved, with the current specifier in the DSM-5 applicable to depressive and bipolar disorders.
Purpose of the Study:
- To present the current understanding of atypical depression, including its definition, prevalence, neurobiology, and treatment.
- To identify future research priorities for atypical depression.
Main Methods:
- Review of historical and current literature on atypical depression.
- Analysis of epidemiological and clinical studies on prevalence.
- Summary of neurobiological research (biochemical, neuroimaging, neurophysiological, neuropsychological).
Main Results:
- Atypical depression is characterized by mood reactivity, hyperphagia, hypersomnia, leaden paralysis, and rejection sensitivity.
- Prevalence estimates vary, with studies suggesting 15%-36% of depressed patients exhibit AD.
- Neurobiological research indicates differences from melancholic depression, though findings are often controversial.
Conclusions:
- Despite research, comprehensive treatment guidelines for atypical depression are lacking.
- Future research should focus on refining diagnostic criteria, conducting genome-wide association studies, and developing updated treatment recommendations.